Saturday, July 11, 2026

pharma · H. Pylori Infection · COVID-19

Jiangsu Province Centers

Jiangsu Province Centers clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
2
Drugs
5
Patents
0
Intelligence · Clinical Programs

Jiangsu Province Centers projects

1 ClinicalTrials.gov programs sponsored by Jiangsu Province Centers.

Jiangsu Province Centers has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. H. pylori vaccine

    Jiangsu Province Centers for Disease Control and Prevention

    H. Pylori Infection

    phase 3 mab completed

    1 trial

Frequently asked questions

How many clinical projects does Jiangsu Province Centers have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.